Timing of potassium monitoring in females treated for acne with spironolactone is not optimal: A retrospective cohort study

J Am Acad Dermatol. 2024 Nov;91(5):982-984. doi: 10.1016/j.jaad.2024.07.1446. Epub 2024 Jul 20.

Authors

Jenny Lai¹, Andrea L Zaenglein², John S Barbieri³

Affiliations

¹ Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
² Department of Dermatology, Penn State Hershey Medical Center, Penn State University, Hershey, Pennsylvania; Department of Pediatrics, Penn State Children's Hospital, Hershey, Pennsylvania.
³ Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: jbarbieri@bwh.harvard.edu.

PMID: 39033981
DOI: 10.1016/j.jaad.2024.07.1446

No abstract available

Keywords: acne; acne treatment; medical dermatology; potassium monitoring; spironolactone.